The phrase "adequate tolerability" is correct and usable in written English.
It can be used in contexts related to medicine, pharmacology, or any field discussing the acceptability of a treatment or intervention's side effects.
Example: "The new medication demonstrated adequate tolerability among patients, with minimal adverse effects reported."
Alternatives: "sufficient tolerability" or "acceptable tolerability".
Daily alendronate has a similar benefit and adequate tolerability even among older female residents of long-term care facilities [ 120].
Thus, a new strategy that is both effective and possesses adequate tolerability would be a very important breakthrough in the adjuvant setting following nephroureterectomy.
New agents with improved efficacy and adequate tolerability would be needed for patients with advanced bladder cancer who have previously received a CDDP-based regimen.
High efficacy, adequate tolerability, acceptable bioavailability with low inter- and intra-individual variability and a limited number of tablets/capsules per day are basic prerequisites and have been limiting factors for oral drug development.
Subsequent studies have explored the combination of ixazomib with lenalidomide in newly diagnosed myeloma, where the combination had high efficacy as well as adequate tolerability to allow for long-term therapy as a maintenance agent.
Kinetic modelling (Higuchi, Korsmeyer-Peppas) was indicative of quasi-Fickian diffusion whilst biological evaluation demonstrates adequate ocular tolerability.
Bruce et al. (abstract 578) studied the same population, finding that transient, mild-to-moderate nausea occurred in 39% of subjects receiving exenatide compared with 9% of control subjects, vomiting in 13% compared with 3%, and pancreatitis in 0.3% compared with 0.3%, suggesting adequate gastrointestinal tolerability of the agent.
It has adequate bioavailability and tolerability.
In this study, MEDI-546 appeared to have an adequate safety and tolerability profile.
In this study, mavrilimumab given as a single, escalating intravenous dose (0.01 10.0 mg/kg) had an adequate safety and tolerability profile in subjects with mild to moderate RA.
18 This study suggested that combination therapy with mitiglinide and voglibose might have adequate safety and tolerability for the treatment of diabetic patients, even those on HD.
